arrow
F

Fernando Caravaca-Fontán

instituto de investigacion hospital 12 de octubre
H指数:27
被引数:2,973

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

活体捐赠与脑死亡后捐赠肾脏移植中的感染并发症

2026-09-250
PRE
Kidney outcomes and prognostic factors in biopsy-proven kidney sarcoidosis: a nationwide multicenter cohort study

肾活检证实的肾脏肉芽肿病的预后结局及影响因素:一项全国多中心队列研究

2026-08-040
OAAI
Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm

狼疮性肾炎的疾病修饰:迈向基于病理生理学的治疗模式

2026-07-230
PRE
'…completely exhausted and weak, really drained.': a multinational qualitative interview study of healthcare provider, patient, and caregiver experiences of C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis diagnosis, burden and management

"...完全耗尽且虚弱,真的筋疲力尽。":一项关于医疗提供者、患者和照护者在C3肾小球病和原发性(特发性)免疫复合物膜增生性肾小球肾炎诊断、负担及管理方面的跨国定性访谈研究

2026-05-010
PRE
Atypical Anti-Glomerular Basement Membrane Disease

非典型抗肾小球基底膜病

2025-12-160
OAAI
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

白蛋白尿作为终末期肾病替代终点的荟萃分析

2025-11-060
PRE
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review

临床表现、治疗模式、疾病负担以及蛋白尿与临床结局的关联:C3肾小球病和原发性免疫复合物膜增生性肾小球肾炎的系统评价

NEPHRON
IF1.8
2025-09-010
PRE
Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial

原发性膜性肾病患者临床缓解的早期预测因子识别:STARMEN试验的<i>post hoc</i>分析

2025-08-130
OA